Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 87, Issue 1, Pages 109-116Publisher
WILEY
DOI: 10.1038/clpt.2009.226
Keywords
-
Categories
Funding
- National Institutes of Health Pharmacogenetics Research Network
- [GM61390]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Since the cloning of the first membrane transporter, our understanding of the role of transporters in clinical drug disposition and response has grown enormously. In parallel, large-scale genome-wide variation studies and the emerging field of pharmacogenomics have ushered in a new understanding of variations in drug response. At the crossroads of pharmacogenomics and transporter biology is the National Institutes of Health-funded Pharmacogenomics of Membrane Transporters (PMT) project, centered at the University of California, San Francisco.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available